Clinical and experimental data showed a detrimental role of inflammatory cytokines in injured brain, and inhibition of IL-1β and TNF-α activity with neutralizing antibodies or soluble receptors decreased neuronal damage in animal models of stroke [4, 5]. The gene discussed is IL1B; the disease is stroke disorder.